Biosino Bio-Technology and Science Inc
08247
Company Profile
Business description
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale and distribution of IVD reagent products. The company operates in single segment the in-vitro diagnostic reagent products segment, which manufactures, sells and distributes a variety of mono/double diagnostic reagent products. Geographically, it generates majority of the revenue from Mainland China.
Contact
No. 27 Chaoqian Road
Science and Technology Industrial Park
Changping District
Beijing102200
CHNT: +86 1080117700
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
499
Stocks News & Analysis
stocks
Another incredible quarter from Microsoft
We were wrong when we thought last quarter would be hard to top.
stocks
10 best US dividend aristocrats to buy now—including a surprise outperformer
These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.
stocks
Leading ASX players in this field look materially overvalued
We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,999.00 | 16.40 | -0.18% |
| CAC 40 | 7,806.38 | 55.58 | -0.71% |
| DAX 40 | 24,090.12 | 172.10 | -0.71% |
| Dow JONES (US) | 44,538.08 | 76.80 | 0.17% |
| FTSE 100 | 9,140.91 | 3.97 | 0.04% |
| HKSE | 24,773.33 | 403.60 | -1.60% |
| NASDAQ | 21,380.46 | 250.79 | 1.19% |
| Nikkei 225 | 41,069.82 | 415.12 | 1.02% |
| NZX 50 Index | 12,823.74 | 32.23 | -0.25% |
| S&P 500 | 6,410.33 | 47.43 | 0.75% |
| S&P/ASX 200 | 8,742.80 | 13.60 | -0.16% |
| SSE Composite Index | 3,573.21 | 42.51 | -1.18% |